Onconetix, Inc. Files 8-K for Security Holder Rights Changes
Ticker: ONCO · Form: 8-K · Filed: Sep 20, 2024 · CIK: 1782107
Sentiment: neutral
Topics: corporate-action, filing, amendment
Related Tickers: ONCO
TL;DR
ONCO filed an 8-K, major changes to security holder rights and corporate docs. Formerly Blue Water Biotech/Vaccines.
AI Summary
Onconetix, Inc. filed an 8-K on September 20, 2024, reporting material modifications to security holder rights and amendments to its articles of incorporation or bylaws. The filing also includes Regulation FD disclosures and financial statements/exhibits. The company was formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc.
Why It Matters
This filing indicates significant corporate actions by Onconetix, Inc. that could impact the rights and structure for its security holders.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and amendments to corporate documents can introduce uncertainty and potential risks for investors.
Key Players & Entities
- Onconetix, Inc. (company) — Registrant
- Blue Water Biotech, Inc. (company) — Former company name
- Blue Water Vaccines Inc. (company) — Former company name
- September 20, 2024 (date) — Date of earliest event reported
FAQ
What specific material modifications were made to the rights of Onconetix, Inc. security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not elaborated upon in the provided text.
What are the key amendments to Onconetix, Inc.'s Articles of Incorporation or Bylaws?
The filing states there were amendments to the Articles of Incorporation or Bylaws, but the specific nature of these amendments is not detailed in the provided text.
When did Onconetix, Inc. change its name from Blue Water Biotech, Inc.?
Onconetix, Inc. changed its name from Blue Water Biotech, Inc. on April 24, 2023.
What is the Standard Industrial Classification for Onconetix, Inc.?
The Standard Industrial Classification for Onconetix, Inc. is Pharmaceutical Preparations [2834].
What is the business address of Onconetix, Inc.?
The business address of Onconetix, Inc. is 201 E. Fifth Street, Suite 1900, Cincinnati, OH 45202.
Filing Stats: 1,210 words · 5 min read · ~4 pages · Grade level 12.2 · Accepted 2024-09-20 11:50:30
Key Financial Figures
- $0.00001 — h registered Common Stock, par value $0.00001 per share ONCO The Nasdaq Stock Mar
Filing Documents
- ea0215232-8k_onconetix.htm (8-K) — 32KB
- ea021523201ex3-1_onconetix.htm (EX-3.1) — 6KB
- ea021523201ex99-1_onconetix.htm (EX-99.1) — 19KB
- 0001213900-24-080508.txt ( ) — 239KB
- onco-20240920.xsd (EX-101.SCH) — 3KB
- onco-20240920_lab.xml (EX-101.LAB) — 33KB
- onco-20240920_pre.xml (EX-101.PRE) — 22KB
- ea0215232-8k_onconetix_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Onconetix, Inc. September 20, 2024 By: /s/ Karina M. Fedasz Name: Karina M. Fedasz Title: Interim Chief Financial Officer 3